The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression ...

ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy ...

A decades-old drug used to lower cholesterol levels in the blood has ... over four years, treatment with fenofibrate resulted in a 27% reduction in the progression of diabetic retinopathy compared ...

The double-drug regimen given for 12 months to four different groups, according to the different combined dosages of simvastatin and fenofibrate, resulted in a reduction in total cholesterol of 18 ...

Paradoxically, fenofibrate reversibly increases serum creatinine such that the drug's benefit on estimated glomerular filtration rate is only unmasked when the artificial creatinine elevation is ...

These drugs cause marked decreases in serum triglyceride levels and moderate increases in HDL cholesterol (HDL-C ... 50 or 100 µg), fenofibrate (200 mg) or placebo for 12 weeks.